Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

Please provide your email address to receive an email when new articles are posted on . The CDC, IDSA and other agencies created updated guidance for treating drug-susceptible and drug-resistant TB.

The World Health Organization (WHO) now recommends shortened treatment for children with mild tuberculosis (TB), as well as two oral TB treatments (bedaquiline and delamanid) for use in children of ...

Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are ...

The World Health Organization is expected to recommend truncating treatment of children with mild tuberculosis by 2 months — from 6 months to 4 — after a randomized trial found similar outcomes with ...

Treating all household contacts of someone with tuberculosis (TB) helped prevent active TB disease across age groups in the real world, but the effectiveness was highest when treating individuals who ...

Germantown, Maryland, and Venlo, the Netherlands, June 27, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it welcomes new guidelines in the United ...

Zimbabwe is set to roll out a Shorter, Highly-effective, Oral Regimen for Rifampicin-resistant Tuberculosis (SHORRT therapy) which reduces the length of treatment for Multi-Drug Resistant Tuberculosis ...